These architectural changes facilitate the upregulation of oncogenic drivers such as SOX4 and GPC3 [87], with SOX4 promoting tumor neovascularization and metastasis [88], while GPC3 activates Wnt signaling to drive HCC growth [89]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.